1. Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, et al. Urologic complications of diabetes. Diabetes Care. 2005. 28:177–185.
Article
2. Kim T, Chung TG, Ahn TY. Relation between lower urinary tract symptoms and erectile dysfunction: epidemiologic study in Jeong-Eup, Korea. Korean J Androl. 1998. 16:87–91.
3. Kim SG, Yang SW, Choi SI, Park SH, Lee KR, Park JH, et al. Prevalence of diabetes mellitus in the elderly of Namwon county, South Korea. Korean J Med. 2001. 60:555–566.
4. Sasayama S, Ishii N, Ishikura F, Kamijima G, Ogawa S, Kanmatsuse K, et al. Men's Health Study: epidemiology of erectile dysfunction and cardiovascular disease. Circ J. 2003. 67:656–656.
5. Seftel AD, Sun P, Swindle R. The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol. 2004. 171:2341–2345.
Article
6. Park KJ, Paick JS. Diabetic erectile dysfunction. Korean J Androl. 2009. 27:135–152.
7. Fonseca V, Seftel A, Denne J, Fredlund P. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia. 2004. 47:1914–1923.
Article
8. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994. 151:54–61.
Article
9. Klein R, Klein BE, Lee KE, Moss SE, Cruickshanks KJ. Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care. 1996. 19:135–141.
Article
10. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia. 1980. 18:279–283.
Article
11. Hatzichristou DG, Seftel A, de Tejada IS. Singer C, Weiner WJ, editors. Sexual dysfunction in diabetes and other autonomic neuropathies. Sexual dysfunction: a neuromedical approach. 1994. Armonk: Futura Publishing Company;167–198.
12. Lee YK, Park BS, Jeong TK, Jeong GH, Ma SK, Kim SW, et al. Erectile dysfunction in diabetic nephropathy. Korean J Med. 2003. 64:188–196.
13. Oh JR, Jeong JY, Jang SN, Choi YJ, Kim DH, Lee SH, et al. Association between erectile dysfunction and metabolic syndrome in aging men: hallym aging study. Korean J Urol. 2009. 50:682–688.
Article
14. Lee SY, Kim SC. Correlation of the serum testosterone level with insulin resistance and metabolic syndrome in patients of erectile dysfunction and benign prostatic hyperplasia. Korean J Urol. 2008. 49:556–561.
Article
15. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Valkonen VP, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004. 27:1036–1041.
Article
16. Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson WG, et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care. 2007. 30:234–238.
17. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ. Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int. 2005. 95:733–738.
Article
18. DuBeau CE. Interpreting the effect of common medical conditions on voiding dysfunction in the elderly. Urol Clin North Am. 1996. 23:11–18.
Article
19. Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol. 2000. 163:1725–1729.
Article
20. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995. 153:342–344.
Article
21. Menéndez V, Cofán F, Talbot-Wright R, Ricart MJ, Gutiérrez R, Carretero P. Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease. J Urol. 1996. 155:2001–2004.
22. Kim JH, Shim BS, Kim JS, Hong YS. Voiding dysfunction of men is associated with metabolic syndrome. Korean J Urol. 2006. 47:257–262.
Article